Dual targeting of transformed and untransformed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF-kappaB, as a strategy for chemoprevention and therapy of adult T-cell leukemia.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples